Literature DB >> 1934422

Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation.

H W Louie1, H Laks, E Milgalter, D C Drinkwater, M A Hamilton, R C Brunken, L W Stevenson.   

Abstract

Because of the shortage of donor hearts, 16 (33%) of 48 patients with ischemic cardiomyopathy died awaiting transplantation. Determining factors that predict effective coronary revascularization and identifying patients who may benefit from revascularization is crucial. From 1984 to 1990, 207 ischemic cardiomyopathy patients were evaluated for heart transplantation; 131 were accepted (83 transplanted), 54 were not accepted, and 22 were revascularized (19 underwent bypass graft surgery and three underwent percutaneous transluminal coronary angioplasty). Four bypass patients failed early (less than or equal to 30 days, three deaths and one urgent heart transplant) and two late deaths (greater than or equal to 1 year) occurred. Overall mortality was 27%. Three-year survival of revascularized and transplanted patients was 72 +/- 10% and 73 +/- 6%, respectively. Successfully revascularized patients had preoperative ejection fraction, left ventricular end-diastolic dimension, and New York Heart Association functional class of 26 +/- 9%, 68 +/- 3 mm, and 3.9 +/- 0.4, respectively, compared with 36 +/- 9% (p less than 0.05), 64 +/- 6 mm (p = NS), and 1.2 +/- 0.4 (p less than 0.05) after revascularization. Preoperative ejection fraction of patients failing revascularization was 15 +/- 4% (p = NS compared with successful revascularization), and left ventricular end-diastolic dimension was 81 +/- 4 mm (p less than 0.05). Preoperative positron emission tomography imaging myocardial blood flow and glucose metabolism was performed in 12 patients: 10 patients with scans predicting reversible ischemia were successfully revascularized, and two patients with negative scans had failed revascularization.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1934422

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

Review 1.  Non-transplant surgery for heart failure.

Authors:  S Westaby
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

2.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

3.  Assessment of myocardial viability after myocardial infarction.

Authors:  Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

Review 4.  Single photon emission computed tomography perfusion imaging for assessment of myocardial viability and management of heart failure.

Authors:  Steven Burrell; Sharmila Dorbala; Marcelo F Di Carli
Journal:  Curr Cardiol Rep       Date:  2003-01       Impact factor: 2.931

5.  Factors influencing predictive value of FDG imaging for evaluating myocardial viability.

Authors:  Jamshid Maddahi
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

6.  [Coronary artery bypass grafting for cases which were not amenable to preoperative left ventriculogram].

Authors:  T Sakamoto; M Endo; H Nishida; Y Tomizawa; S Kihara; H Koyanagi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-10

7.  Clinical cardiac PET: quo vadis?

Authors:  H R Schelbert; J Maddahi
Journal:  J Nucl Cardiol       Date:  1994 Nov-Dec       Impact factor: 5.952

8.  Surgical ventricular restoration: an operation to reverse remodeling - the basic science (part I).

Authors:  Ganesh Shanmugam; Imtiaz S Ali
Journal:  Curr Cardiol Rev       Date:  2009-11

9.  Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-10-01

10.  Incremental prognostic value of left ventricular function by myocardial ECG-gated FDG PET imaging in patients with ischemic cardiomyopathy.

Authors:  Cesar A Santana; Leslee J Shaw; Ernest V Garcia; Marina Soler-Peter; J Candell-Riera; Gabriel B Grossman; Elizabeth G Krawczynska; Tracy L Faber; Aida Ribera; Viola Vaccarino; Raghuveer Halkar; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.